NMR Valuation

Nomura Holdings Inc

Add to Watchlist

Advanced Chart

7.070

+0.11(1.580%)1D

NMR Relative Valuation

NMR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NMR is overvalued; if below, it's undervalued.

Historical Valuation

Nomura Holdings Inc (NMR) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.74 is considered Undervalued compared with the five-year average of 10.71. The fair price of Nomura Holdings Inc (NMR) is between 7.78 to 14.46 according to relative valuation methord. Compared to the current price of 6.96 USD , Nomura Holdings Inc is Undervalued By 10.53%.

Relative Value

Fair Zone

7.78-14.46

Current Price：6.96

10.53%

Undervalued

9.74

Trailing

Forward

0.00

EV/EBITDA

Nomura Holdings Inc. (NMR) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

NaN

EV/EBIT

Nomura Holdings Inc. (NMR) has a current EV/EBIT of NaN. The 5-year average EV/EBIT is NaN. The thresholds are as follows: Strongly Undervalued below NaN, Undervalued between NaN and NaN, Fairly Valued between NaN and NaN, Overvalued between NaN and NaN, and Strongly Overvalued above NaN. The current Forward EV/EBIT of NaN falls within the range.

1072.70

Nomura Holdings Inc. (NMR) has a current PS of 1072.70. The 5-year average PS is 5.74. The thresholds are as follows: Strongly Undervalued below -132.42, Undervalued between -132.42 and -63.34, Fairly Valued between 74.82 and -63.34, Overvalued between 74.82 and 143.90, and Strongly Overvalued above 143.90. The current Forward PS of 1072.70 falls within the Strongly Overvalued range.

0.00

P/OCF

Nomura Holdings Inc. (NMR) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Nomura Holdings Inc. (NMR) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Nomura Holdings Inc (NMR) has a current Price-to-Book (P/B) ratio of 0.90. Compared to its 3-year average P/B ratio of 0.68 , the current P/B ratio is approximately 31.85% higher. Relative to its 5-year average P/B ratio of 0.64, the current P/B ratio is about 40.06% higher. Nomura Holdings Inc (NMR) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -28.47%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -29.73% , the current FCF yield is about -100.00% lower.

0.90

P/B

Median3y

0.68

Median5y

0.64

0.00

FCF Yield

Median3y

-28.47

Median5y

-29.73

Competitors Valuation Multiple

The average P/S ratio for NMR's competitors is 444.76, providing a benchmark for relative valuation. Nomura Holdings Inc Corp (NMR) exhibits a P/S ratio of 1072.70, which is 141.18% above the industry average. Given its robust revenue growth of 2.33%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Goldman Sachs Group Inc

Robinhood Markets Inc

Performance Decomposition

Market capitalization of NMR increased by 14.47% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 5.87 to 9.29.

The secondary factor is the Revenue Growth, contributed 2.33%to the performance.

Overall, the performance of NMR in the past 1 year is driven by Margin Expansion. Which is more sustainable.

2.33%

7.81B → 8.00B

Revenue Growth

58.26%

5.87 → 9.29

Margin Expansion

-46.12%

16.46 → 8.87

P/E Change

14.47%